Actively Recruiting
Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study
Led by Dana-Farber Cancer Institute · Updated on 2026-04-22
364
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
Sponsors
D
Dana-Farber Cancer Institute
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates the effectiveness of a Shared Decision-Making (SDM) toolkit designed to support older breast cancer survivors aged 80 and above in making informed decisions about continuing surveillance mammography.
CONDITIONS
Official Title
Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 60 80 years at the time of registration
- History of stage 0-III breast cancer including ductal carcinoma in situ or invasive breast cancer of any subtype
- No history of recurrent breast cancer considered metastatic or locoregional recurrence by clinician judgement
- At least one intact breast
- Mammogram screening or surveillance within the last 24 months
- At least 12 months since most recent breast surgery to the affected breast
- No active cancer treatment except hormonal therapy or CDK 4/6 inhibitor therapy
- Ability and willingness to take surveys
- Receiving some oncology follow-up care at a participating site
- Most recent mammogram report did not recommend additional diagnostic work-up or close interval follow-up imaging, or any required diagnostic testing was resolved to benign findings
You will not qualify if you...
- Inability to provide informed consent
- Assigned male sex at birth
- Breast or recent imaging findings requiring diagnostic testing at baseline
- Prior discontinuation of mammography by medical record or patient report
- Prior atypical ductal hyperplasia or non-pleomorphic lobular carcinoma in situ only
- Psychiatric illness limiting study compliance
- Metastatic breast cancer
- Receiving hospice care
- Clinician unwilling to participate
- Pregnant women, young patients, or those in prison
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
R
Rachel Freedman, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here